FIASP PENFIL 1

About

FIASP PENFIL contains fast-acting Insulin Aspart, a rapid-acting insulin analogue specifically engineered for mealtime use in individuals with type 1 and type 2 diabetes mellitus. This innovative formulation incorporates niacinamide (vitamin B3) to accelerate its initial absorption from the subcutaneous injection site, resulting in a significantly faster onset of action compared to conventional rapid-acting insulins. This accelerated action allows for greater flexibility in administration, as it can be taken at the start of a meal or up to 20 minutes after commencing a meal, accommodating varying eating habits. FIASP is highly effective in controlling postprandial glucose excursions, thereby preventing sharp spikes in blood sugar levels that typically occur after eating. It is a vital component of intensive insulin regimens, providing precise and timely glucose management to improve overall glycemic control and reduce the risk of hyperglycemia.

Uses

• Mealtime insulin for type 1 diabetes.
• Mealtime insulin for type 2 diabetes.
• Control of postprandial hyperglycemia.
• Flexible dosing around meals.

Directions For Use

Administer subcutaneously at the start of a meal or up to 20 minutes after starting a meal.

Benefits

• Ultra-rapid onset of action.
• Greater flexibility in dosing time.
• Effective postprandial glucose control.
• Reduces blood sugar spikes after meals.
• Can be used in insulin pumps.
• Improved convenience for patients.

Side Effects

• Hypoglycemia (low blood sugar)
• Injection site reactions (pain, redness, swelling)
• Lipodystrophy
• Weight gain
• Peripheral edema
• Allergic reactions (rare)
• Rash
• Pruritus
• Urticaria
• Blurred vision (transient)
• Diabetic retinopathy worsening (transient)
• Hypokalemia (rare)

Safety Measures

• Alcohol - Alcohol can lower blood sugar; use with caution and monitor glucose levels.
• Pregnancy - Consult a doctor; insulin needs may change during pregnancy.
• Breastfeeding - Generally considered safe; monitor infant for hypoglycemia.
• Liver - Use with caution; dose adjustment may be needed in severe impairment.
• Kidney - Use with caution; dose adjustment may be needed in severe impairment.
• Lung - No specific contraindications; manage diabetes carefully in patients with lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.